Revive Therapeutics Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$4.07 M |
Shares Outstanding |
24.88 M |
Public Float |
- |
Revive Therapeutics Ltd. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.02 |
Market Cap |
CAD5.47 M |
Shares Outstanding |
35.9 M |
Public Float |
25.69 M |
Address |
5 Director Court Vaughan Ontario L4L 4S5 Canada |
Employees | - |
Website | http://www.revivethera.com |
Updated | 07/08/2019 |
Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It identifies and investigate potential therapies targeting the endocannabinoid system, such as cannabinoids. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Vaughan, Canada. |